Kerem Özer

Pathogenesis of A−β+ Ketosis-Prone Diabetes

Sanjeet Patel, Jean W. Hsu, Farook Jahoor et al. · Diabetes · 2012 · 72 citations · Full text

Life Sciences, Biochemistry, Nutrition +17

Presence or absence of a known diabetic ketoacidosis precipitant defines distinct syndromes of “A-β+” ketosis-prone diabetes based on long-term β-cell function, human leukocyte antigen class II alleles, and sex predilection

Ramaswami Nalini, Kerem Özer, Mario Maldonado et al. · Metabolism · 2010 · 57 citations · Full text

Medicine, Endocrinology, Internal Medicine +13

Gene Therapy with Neurogenin 3 and Betacellulin Reverses Major Metabolic Problems in Insulin-Deficient Diabetic Mice

Vijay Yechoor, Victoria Liu, Antoni Paul et al. · Endocrinology · 2009 · 38 citations · Full text

Medicine, Endocrinology, Molecular Biology +16

Fast Acting Insulin Aspart Compared with Insulin Aspart in the Medtronic 670G Hybrid Closed Loop System in Type 1 Diabetes: An Open Label Crossover Study

Kerem Özer, Alison M. Cooper, Lily P. Ahn et al. · Diabetes Technology & Therapeutics · 2020 · 36 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +16

Islet-Specific T-Cell Responses and Proinflammatory Monocytes Define Subtypes of Autoantibody-Negative Ketosis-Prone Diabetes

Barbara Brooks‐Worrell, Dinakar Iyer, Ivonne Coraza et al. · Diabetes Care · 2013 · 34 citations · Full text

Medicine, Endocrinology, Immunology +15